A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aluminium monostearate
Lithium hydroxide
Dexibuprofen may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Aluminium monostearate
Lithium carbonate
Dexibuprofen may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Aluminium monostearate
Lithium citrate
Dexibuprofen may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
Aluminium monostearate
Drospirenone
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Drospirenone.
Aluminium monostearate
Acetyldigoxin
Dexibuprofen may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Aluminium monostearate
Metildigoxin
Dexibuprofen may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Aluminium monostearate
Deferasirox
The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Dexibuprofen is combined with Deferasirox.
Aluminium monostearate
Naxitamab
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Naxitamab.
Aluminium monostearate
Aripiprazole lauroxil
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Aripiprazole lauroxil.
Aluminium monostearate
5-methoxy-N,N-dimethyltryptamine
The risk or severity of hypertension can be increased when Dexibuprofen is combined with 5-methoxy-N,N-dimethyltryptamine.
Aluminium monostearate
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of hypertension can be increased when Dexibuprofen is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
Aluminium monostearate
Deoxyepinephrine
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Deoxyepinephrine.
Aluminium monostearate
Harmaline
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Harmaline.
Aluminium monostearate
Mefenorex
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Mefenorex.
Aluminium monostearate
Imipramine oxide
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Imipramine oxide.
Aluminium monostearate
Xamoterol
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Xamoterol.
Aluminium monostearate
Prenalterol
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Prenalterol.
Aluminium monostearate
Gepefrine
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Gepefrine.
Aluminium monostearate
Tretoquinol
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Tretoquinol.
Aluminium monostearate
Methoxyphenamine
The risk or severity of hypertension can be increased when Dexibuprofen is combined with Methoxyphenamine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3